Inventor
WEBSTER KEVIN R
US12 patents
⚠️ This page may combine multiple inventors who share the name “WEBSTER KEVIN R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
8 patentsUS6262096B1Jul 17, 2001
Aminothiazole inhibitors of cyclin dependent kinases
BRISTOL MYERS SQUIBB CO81 citations96
US6107305AAug 22, 2000
Use of pyrazolo [3,4-b] pyridine as cyclin dependent kinase inhibitors
BRISTOL MYERS SQUIBB CO88 citations96
US6040321AMar 21, 2000
Aminothiazole inhibitors of cyclin dependent kinases
BRISTOL MYERS SQUIBB CO85 citations96
US6720347B2Apr 13, 2004
Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
BRISTOL MYERS SQUIBB CO32 citations92
US6407124B1Jun 18, 2002
Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
BRISTOL MYERS SQUIBB CO26 citations92
US5625031AApr 29, 1997
Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
BRISTOL MYERS SQUIBB CO44 citations91
US6521759B2Feb 18, 2003
Aminothiazole inhibitors of cyclin dependent kinases
BRISTOL MYERS SQUIBB CO6 citations73
US6534531B2Mar 18, 2003
Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
BRISTOL MYERS SQUIBB CO5 citations60
EFFECTOR THERAPEUTICS INC
4 patentsUS10702526B2Jul 7, 2020
Inhibitors of immune checkpoint modulators and related methods
EFFECTOR THERAPEUTICS INC2 citations72
US11564947B2Jan 31, 2023
Methods and compositions for cellular immunotherapy
EFFECTOR THERAPEUTICS INC0 citations57
US10780119B2Sep 22, 2020
Methods and compositions for cellular immunotherapy
EFFECTOR THERAPEUTICS INC1 citations57
US11576933B2Feb 14, 2023
Compositions and methods for an improved antitumor immune response
EFFECTOR THERAPEUTICS INC0 citations47